WHAT WE DO
We investigate the molecular events of amyloid aggregation, amyloid toxicity, and analyze pathways of neuronal dysfunction. Our current projects are directed to develop pharmacological strategies for prevention and therapy.
Amyloid toxicity and anti-amyloid strategies
Enzyme mediated clearance of misfolded peptides and proteins in late-stage neurodegenerative diseases with a focus on Alzheimer's disease
Nanomaterials for therapy and biomarkers for diagnosis